Navigation Links
Post-Op Chemo Fails to Boost Survival in Stomach Cancers
Date:3/11/2008

Drug-surgery combo showed no significant improvement in outcomes, study finds

TUESDAY, March 11 (HealthDay News) -- Chemotherapy following surgery does not improve survival in stomach cancer patients, says an Italian study.

Currently, surgery is the only treatment that can potentially cure non-metastatic gastric cancer, according to background information in the study. However, some recent research has suggested that a chemotherapy combination of cisplatin, epirubicin, 5-fluorouracil and leucovorin (PELF) improves outcomes in people with metastatic gastric cancer.

In this study, researchers tested the PELF combination in patients with localized gastric cancer. Some of the 258 patients in the study were treated with surgery only, while others had surgery followed by chemotherapy.

At a median follow-up of 72.8 months, there was no statistical difference between the two groups in terms of disease-free survival or overall survival. Disease progression occurred in 47.7 percent of patients in the surgery/chemotherapy group and in 51.6 percent of those in the surgery group.

The survival rate was 47 percent in the surgery/chemotherapy group and 45.3 percent in the surgery group.

The study was published in the March 11 online issue of the Journal of the National Cancer Institute.

"Our study confirms that a dose-intense regimen like PELF, which showed very promising results in advanced gastric cancer, is not effective in an adjuvant setting," wrote the researchers from the University Hospital Careggi in Florence and the Italian Oncology Group for Cancer Research. Based on these and other recent negative findings, the authors concluded: "Adjuvant chemotherapy alone remains a controversial approach in operable gastric cancer."

In an accompanying editorial, two doctors at the Beijing Cancer Hospital and Institute in China discuss conflicting findings from recent trials examining the use of chemotherapy and radiation to treat patients with localized gastric cancer.

Even though overall data is inconsistent, chemotherapy, radiation or a combination of the two should be used in patients with localized gastric cancer, said Dr. Aiwen Wu and Dr. Jiafu Ji.

"Surgery alone is no longer the standard treatment for patients with resectable gastric cancer, independent of the patient population or the practice location," they wrote.

More information

The American Cancer Society has more about stomach cancer.



-- Robert Preidt



SOURCE: Journal of the National Cancer Institute, news release, March 11, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Gene Tied to Post-Op Delirium in Elderly
2. UI nursing researcher to study post-operative pain control
3. Flynn Pharma Acquires Rights From Pacira Pharmaceuticals to DepoDur(R), the Only Extended-Release Epidural Opioid for Post-Operative Pain, in Europe
4. Acupuncture Cuts Need for Post-Op Painkillers
5. Chewing gum -- the new post-operative medicine
6. Chemotherapy may be culprit for fatigue in breast cancer survivors
7. Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
8. To evade chemotherapy, some cancer cells mimic stem cells
9. New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas
10. PET scans can accurately detect a breast tumors response to chemotherapy
11. Chemotherapy with gemcitabine delays progression of operable pancreatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Post-Op Chemo Fails to Boost Survival in Stomach Cancers
(Date:9/23/2017)... ... September 23, 2017 , ... A ... fighting obesity of Robert Kushner, director of Chicago’s Center for Lifestyle Medicine at ... healthier habits, the article notes that the center routinely recommends weight loss surgeries ...
(Date:9/23/2017)... ... September 23, 2017 , ... “You Can't Win Them All”: the ... their business ventures and on the ice changed the lives of young athletes. ... Cosimo Filane was born and educated in Schreiber, a small town in Northern Ontario, ...
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... On Sunday, ... Walk and 5K honoring Olympian, Florence Joyner, still considered the fastest woman of all ... Flo Jo’s daughter, Mary Joyner, will sing the National Anthem. Mary was ...
(Date:9/22/2017)... Plano, TX (PRWEB) , ... September 22, 2017 , ... ... created to strengthen the communities they serve as part of the nationally recognized ‘Agents ... by working closely with nonprofit organizations and community leaders to seek out those who ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... and financial setbacks, a senior finds a new lease on life with assistance ... thousands of people resolve their problem with unsecured debt. The senior is one ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
(Date:9/1/2017)... 1, 2017  Bayer will present the latest research from ... Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... preclinical and clinical data on Bayer,s marketed portfolio and late-stage ... "We value the ... cancer research at ESMO," said Carsten Brunn , Head ...
(Date:8/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will ... September 11, 2017, in New York . ... is scheduled to present at 11:05 a.m. Eastern Time. ... http://ir.hill-rom.com/events.cfm . A recorded replay will be available one ... 10, 2017. About ...
Breaking Medicine Technology: